Apo‐E never was discriminative in function of CAD aggravation and was discarded from our ‘CAD aggravation panel’, finally combining MMP‐9, TIMP‐2 and Apo‐CIII with best AUC. This evidence concerns the gene APOC3 and coronary artery disorder.